Leiden-based Agtech scaleup In Ovo secures €34M to prevent killing of day-old male chicks
HQ: NL
Founded: 2013
Series B
Sector: Biotechnology
Investment Raised: EUR 34M €
Valuation Remains Undisclosed
Investors: ABN AMRO Fund (https://www.abnamro.com/en/about-abn-amro/product/abnamro-ventures) Demcon (https://demcon.com) European Circular Bioeconomy Fund (https://www.ecbf.vc) Evonik Venture Capital (https://venturing.evonik.com/en) VisVires New Protein (https://www.visviresnewprotein.com)
Centauri Therapeutics Closes £24 Million GBP Series A Investment Round
HQ: UK
Founded: 2015
Series A
Sector: Biotechnology
Investment Raised: GBP 24M €
Valuation Remains Undisclosed
Investors: Animatrix Founders (https://www.crunchbase.com/organization/animatrix-founders) Boehringer Ingelheim Venture Fund (https://www.boehringer-ingelheim-venture.com/) Evotec (https://www.evotec.com/en) Kent Life Science LLP (http://www.checkcompany.co.uk/company/OC420283/KENT-LIFE-SCIENCE-%28GP%29-LLP) Novo Holdings (https://www.novoholdings.dk/) Wren Capital (https://www.wrencapital.co.uk/)
Dutch insect farming startup Protix raises €50M to bring the food system back in balance with nature; here’s how
HQ: NE
Founded: 2009
Private Equity
Sector: Biotechnology
Investment Raised: EUR 50M €
Valuation Remains Undisclosed
Investors: Aqua Spark (https://www.aqua-spark.nl/) BNP Paribas (https://www.bnpparibas.at/en/) European Circular Bioeconomy Fund (https://www.ecbf.vc/) Invest-NL (https://www.invest-nl.nl/) Prince Albert II of Monaco Foundation (https://www.fpa2.org/en/index) Rabo Corporate Investments (https://raboinvestments.com/) The Good Investors (https://thegoodinvestors.com/)
Microbiotica Raises £50m to Advance Pipeline of Microbiome-based Therapeutics
HQ: UK
Founded: 2016
Series B
Sector: Biotechnology
Investment Raised: GBP 50M €
Valuation Remains Undisclosed
Investors: Tencent (https://www.tencent.com/) Seventure Partners (http://www.seventure.fr/en/) IP Group (https://www.ipgroupplc.com/) Flerie Invest (https://flerie.com/) Cambridge Innovation Capital (https://www.cic.vc/) British Patient Capital (https://www.britishpatientcapital.co.uk/)
Nuclera raises $42.5M towards launch of new protein 3D printer that “makes drug discovery accessible”
HQ: UK
Founded: 2013
Series B
Sector: Biotechnology
Investment Raised: USD 42.5M €
Valuation Remains Undisclosed
Investors: Amadeus Capital Partners (https://www.amadeuscapital.com/) British Business Bank (https://www.british-business-bank.co.uk/) E Ink (https://www.eink.com/) Future Planet Capital (https://futureplanetcapital.com/) G. K. Goh (https://www.gkgoh.com/) M&G Investments (https://www.mandg.com/) RT Partners (https://www.crunchbase.com/organization/rt-partners)
